Financhill
Sell
18

ALT Quote, Financials, Valuation and Earnings

Last price:
$4.00
Seasonality move :
10.8%
Day range:
$3.98 - $4.16
52-week range:
$2.90 - $8.25
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
15,865.35x
P/B ratio:
2.25x
Volume:
6.8M
Avg. volume:
4.2M
1-year change:
-48.45%
Market cap:
$416.8M
Revenue:
$20K
EPS (TTM):
-$1.07

Earnings Data

Next earnings date for ALT
Feb 26
2026
Most recent earnings per share
-$0.21
Beat by $0.05
(Nov 6/2025)
Consensus Estimate
-$0.27
(Nov 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ALT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/26/2026 Q4 $560 -- -- -$0.24 --
11/06/2025 Q3 $560 $5K -$0.21 -$0.27 $0.05
08/12/2025 Q2 $560 $5K -$0.27 -$0.32 $0.05
05/15/2025 Q1 $560 $5K -$0.26 -$0.34 $0.08
02/27/2025 Q4 -- $5K -$0.33 -$0.34 $0.01
11/12/2024 Q3 $620 $5K -$0.32 -$0.36 $0.04
08/08/2024 Q2 $620 $5K -$0.35 -$0.35 -$0.01
05/09/2024 Q1 -- $5K -$0.34 -$0.35 $0.01
03/27/2024 Q4 $2.1K $37K -$0.56 -$0.38 -$0.18
11/07/2023 Q3 -- -- -$0.39 -$0.44 $0.05
08/10/2023 Q2 -- -- -$0.32 -$0.46 $0.14
05/11/2023 Q1 -- -- -$0.40 -$0.48 $0.08
02/28/2023 Q4 -- -- -$0.43 -$0.54 $0.11
11/10/2022 Q3 -- -- -$0.48 -$0.51 $0.03
08/11/2022 Q2 -- -- -$0.42 -$0.50 $0.08
05/12/2022 Q1 -- -- -$0.44 -$0.58 $0.14
03/15/2022 Q4 -- -- -$0.57 -$0.69 $0.12
11/10/2021 Q3 -- -- -$0.81 -$0.39 -$0.42
08/11/2021 Q2 -- -- -$0.60 -- --
05/17/2021 Q1 -- -- -$0.38 -- --
02/25/2021 Q4 -- -- -$0.17 -- --
11/10/2020 Q3 -- -- -$0.54 -- --
08/12/2020 Q2 -- -- -$0.94 -- --
05/14/2020 Q1 -- -- -$0.26 -- --
03/25/2020 Q4 -- -- -$0.25 -- --
11/14/2019 Q3 -- -- -$0.74 -- --
08/14/2019 Q2 -- -- -$0.26 -- --
05/15/2019 Q1 -- -- -$0.27 -- --
12/31/2018 Q4 -- -- -$2.79 -- --
09/30/2018 Q3 -- -- -$1.73 -- --
06/30/2018 Q2 -- -- -$10.29 -- --
03/31/2018 Q1 -- -- -$7.49 -- --
12/31/2017 Q4 -- -- -$16.15 -- --
11/09/2017 Q3 -- -- -$61.57 -- --
08/10/2017 Q2 -- -- -$7.80 -- --
05/03/2017 Q1 -- -- -$20.40 -- --
03/14/2017 Q4 -- -- -$13.80 -- --
11/04/2016 Q3 -- -- -$21.30 -- --
08/04/2016 Q2 -- -- -$7.50 -- --
05/09/2016 Q1 -- -- -$6.00 -- --
03/11/2016 Q4 -- -- -$6.00 -- --

Altimmune, Inc. Earnings Questions

  • How Much did Altimmune, Inc. Generate in Revenue Last Quarter?

    Altimmune, Inc. reported $5K worth of top line sales in its most recent quarter.

  • Did Altimmune, Inc. Beat Earnings Last Quarter?

    Altimmune, Inc. announced earnings per share of -$0.21 which represents a beat of analyst forecast a -$0.27 per share.

  • Is Altimmune, Inc. Profitable?

    Altimmune, Inc. reported -$22K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Altimmune, Inc. EPS Next Year?

    Altimmune, Inc.'s earnings are forecast to decrease from -$1.34 per share to -$1.34 per share next year representing a decrease of -27.01%.

  • When is Altimmune, Inc.'s Earnings Date?

    Altimmune, Inc.'s next earnings date is February 26, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 24

Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock